A Single Ascending Dose Study of PCO371 in Healthy Volunteers

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

This is a single-center, placebo-controlled, randomized, double-blind, dose-escalation study to evaluate safety, tolerability, and PK of a single oral (PO) administration of PCO371 in healthy adult males. Caucasian and Japanese subjects will be randomized to receive either PCO371 or placebo.

Key facts

Study ID

NCT02475616

Run by

Chugai Pharmaceutical

People needed

64

Starts

2015-06-01

Expected to finish

2015-10-01

Last updated by the study team

2015-11-20

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy male volunteers aged 18 to 45 years.
• Caucasian(BMI 18-30 mg/kg2) or first generation japanese(BMI 18-25kg/m2)
• Able and willing to abide by the protocol

You may not qualify if…

• Evidence of any medical condition that could affect renal, hepatic, or cardiopulmonary functions.

Where it is running

• Wcct Global — Cypress, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.